Ann: NWR Virtual Healthcare Conference Presentation, page-2

In the presentaion today professor Trent Munro confirmed that the first in vitro screening results for autoimmune diseases in partnership with Ginko Bioworks have been received and will be reported to market this month ( sometime over next 10 days ).

Interesting that the first FDA approved Rebiotix faecal donor derived enema product relies on actual donors as does the next to be FDA approved Seres faecal donor derived ORAL capsule drug product which makes them very problematical. Microba's future products will be replicating the applicable microbiome as lab manufactured which makes it hugely more scalable and more accurately targeted.